Scott McNealy’s Wayin Launches Disruptive Digital

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
147
Scott McNealy’s Wayin Launches Disruptive Digital Marketing Service to Enhance Customer Engagement

DENVER, March 15, 2017 (GLOBE NEWSWIRE) -- Wayin, the leading digital campaign content management system (CMS), today has launched the Wayin App Store , a customizable library of marketing campaigns that streamlines the campaign ideation and creation process across markets, divisions and brands. Through the App Store, brands can customize and optimize previous campaigns and re-launch them in different geographies, maximizing the reach of conversion-driving interactive marketing experiences.

Wayin’s App Store enables brands to access a private collection of all campaigns and digital experiences previously executed through the Wayin CMS. Details about each campaign, such as specific features, key objectives and results metrics help marketers identify the right campaign in the App Store to help them achieve their goals.

“The cyclical nature of marketing means campaigns are continually responding to the same cultural moments every year, whether it’s Christmas, Thanksgiving, or the Superbowl,” said Richard Jones, Wayin CEO. “Unfortunately, most global companies end up recreating similar digital experiences year after year, wasting a huge amount of time and resources. Through the Wayin App Store, brand marketers can analyze metrics from previous campaigns in different countries and divisions, then select one that is relevant to their goals and build on it to target consumers in their market, making campaigns more engaging for consumers and easier to execute for marketers.”

With 40–60 percent of the average ad budget spent on non-working media, such as agency fees, digital product builds, and content manufacturing, brands are continually wasting time and resources on reinventing the wheel with every campaign. The Wayin App Store drastically reduces non-working media costs over time by empowering brands to build on existing digital campaigns that have proven to be successful.

Along with the App Store, Wayin has rolled out a series of new service expansion apps that enable brands to integrate more creative, interactive features into their campaigns. Applications include a meme-generator, live social maps to enrich storytelling, ad unit integration for more dynamic experiences, Facebook Live and Periscope voting and charting, chatbot creation, augmented reality experiences and prize fulfillment capabilities. These features enable brands to drive further engagement through interactive digital experiences on exciting new channels.

“Traditional digital marketing such as video, retargeting and native advertisements have proven to be far less effective than initially anticipated and brands are struggling to drive significant revenue from today’s standard advertising tactics,” said Scott McNealy, Wayin founder and executive chairman of the board. “Wayin’s innovative CMS focuses on interactive experiences for consumers, driving far more valuable results than simple content impressions. We are also exploring new channels and leveraging next-generation technology such as chat bots, augmented reality, Snapchat Ads and live social broadcasting to truly engage consumers. What iTunes did for music and Google Play did for online media, the Wayin App Store is doing for digital campaign experiences.”

This announcement comes on the heels of Wayin’s acquisition of UK-based interactive marketing platform, EngageSciences, in 2016. The combined platform gives modern-day marketers all the tools they need to deliver authentic campaign experiences across all digital properties.

For more information, visit www.wayin.com/app-store-launch/ .

About Wayin Wayin, the Digital Campaign CMS platform enables marketers and agencies to deliver authentic interactive campaign experiences across all digital properties including web, social, mobile and partner channels. Wayin services more than 300 brands across 80 countries and 10 industries including leaders like CNN, Coca Cola, MLB, AOL, Discovery and Vodafone.

Francesca Heath Communications Director francesca@wayin.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 0

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 0

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Conformal Coatings Market Set for Significant Growth by 2032

Updated Category News Views 233

The conformal coatings market surged ahead with projections showing it could reach USD 1.7 billion by 2032. This translates into a compound annual growth rate (CAGR) of 5.7% from 2024 to 2032, driven primarily by advancements in electronic protection technologies. Traders had better keep their eyes peeled—this ain't just a bump; it's a substantial shift. What’s...

Continue Reading
Japanese Mobile Battery Industry Forecasts Significant Growth

Updated Category News Views 122

Japan Mobile Battery Market Overview The mobile battery market in Japan is witnessing significant growth, with a valuation of JPY 207.96 billion in 2024 and projected to escalate to JPY 358.97 billion by 2033, marking a compound annual growth rate (CAGR) of 6.48% from 2025 to 2033. This growth trajectory highlights not only increasing consumer demands but also rapidly...

Continue Reading
Givastomig: A Promising Player in Gastric Cancer Therapy

Updated Category News Views 74

Givastomig's Advances in Gastric Cancer Research I-Mab (NASDAQ: IMAB), a biotech firm focused on developing cancer immunotherapies, recently presented exciting results from its Phase 1 clinical trial involving givastomig. This innovative bispecific antibody immunostimulant was unveiled at a prominent medical conference, demonstrating its effectiveness in treating advanced...

Continue Reading
Rani Therapeutics Partners with Chugai for Drug Delivery Breakthrough

Updated Category News Views 245

Rani Therapeutics Engages with Chugai Pharmaceutical Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) recently announced a significant collaborative effort with Chugai Pharmaceutical Co., Ltd., resulting in an enthusiastic response from investors. This collaboration aims to utilize Rani's innovative RaniPill oral drug delivery system alongside Chugai's experimental...

Continue Reading
Revizto's Brand Revamp: A Bold Step Towards Future Growth

Updated Category News Views 142

Revizto Introduces a Fresh Brand Identity As project complexities continue to rise in the construction industry, Revizto is making important modifications to its public image. The renowned collaboration platform, specifically designed for the Architecture, Engineering, Construction, and Operations (AECO) sectors, recently unveiled its refreshed brand identity,...

Continue Reading